Advertisement
Screener

Standard BioTools Inc. (LAB) Shares Authorized

2.8 / 5 stars · 68/120 Roast Me

Standard BioTools Inc. Shares Authorized

Standard BioTools Inc. (LAB) had Shares Authorized of 600.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:CommonStockSharesAuthorized · last filed 2026-08-05

  • 2026-06-30: Common Stock, Shares Authorized 600.00M shares.
  • 2026-03-31: Common Stock, Shares Authorized 600.00M shares.
  • 2025-12-31: Common Stock, Shares Authorized 600.00M shares.
  • 2025-09-30: Common Stock, Shares Authorized 600.00M shares.
Period endCommon Stock, Shares Authorized
2026-06-30600.00M shares
10-Q · filed 2026-08-05
2026-03-31600.00M shares
10-Q · filed 2026-05-06
2025-12-31600.00M shares
10-Q · filed 2026-08-05
2025-09-30600.00M shares
10-Q · filed 2025-11-04
2025-06-30600.00M shares
10-Q · filed 2025-08-15
2025-03-31600.00M shares
10-Q · filed 2025-05-06
2024-12-31600.00M shares
10-K · filed 2026-03-16
2024-09-30600.00M shares
10-Q · filed 2024-11-06
2024-06-30600.00M shares
10-Q · filed 2024-08-06
2024-03-31600.00M shares
10-Q · filed 2024-05-09
2023-12-31400.00M shares
10-K · filed 2025-03-11
2023-09-30400.00M shares
10-Q · filed 2023-11-07
2023-06-30400.00M shares
10-Q · filed 2023-08-08
2023-03-31400.00M shares
10-Q · filed 2023-05-09
2022-12-31400.00M shares
10-K · filed 2024-03-01
2022-09-30400.00M shares
10-Q · filed 2022-11-09
2022-06-30400.00M shares
10-Q · filed 2022-08-09
2022-04-04400.00M shares
10-K · filed 2023-03-14
2022-04-03200.00M shares
10-K · filed 2023-03-14
2022-04-01400.00M shares
10-Q · filed 2023-05-09
2022-03-31200.00M shares
10-Q · filed 2023-05-09
2021-12-31200.00M shares
10-K · filed 2023-03-14
2021-09-30200.00M shares
10-Q · filed 2021-11-09
2021-06-30200.00M shares
10-Q · filed 2021-08-06
2021-03-31200.00M shares
10-Q · filed 2021-05-07
2020-12-31200.00M shares
10-K · filed 2022-03-08
2020-09-30200.00M shares
10-Q · filed 2020-11-09
2020-06-30200.00M shares
10-Q · filed 2020-08-07
2020-03-31200.00M shares
10-Q · filed 2020-05-11
2019-12-31200.00M shares
10-K · filed 2021-02-25
2019-09-30200.00M shares
10-Q · filed 2019-11-08
2019-06-30200.00M shares
10-Q · filed 2019-08-07
2019-03-31200.00M shares
10-Q · filed 2019-05-07
2018-12-31200.00M shares
10-K · filed 2020-02-27
2018-09-30200.00M shares
10-Q · filed 2018-11-06
2018-06-30200.00M shares
10-Q · filed 2018-08-08
2018-03-31200.00M shares
10-Q · filed 2018-05-08
2017-12-31200.00M shares
10-K · filed 2019-03-18
2017-09-30200.00M shares
10-Q · filed 2017-11-07
2017-06-30200.00M shares
10-Q · filed 2017-08-08
2017-03-31200.00M shares
10-Q · filed 2017-05-09
2016-12-31200.00M shares
10-K · filed 2018-03-08
2016-09-30200.00M shares
10-Q · filed 2016-11-09
2016-06-30200.00M shares
10-Q · filed 2016-08-09
2016-03-31200.00M shares
10-Q · filed 2016-05-09
2015-12-31200.00M shares
10-K · filed 2017-03-03
2015-09-30200.00M shares
10-Q · filed 2015-11-09
2015-06-30200.00M shares
10-Q · filed 2015-08-10
2015-03-31200.00M shares
10-Q · filed 2015-05-11
2014-12-31200.00M shares
10-K · filed 2016-02-29
2014-09-30200.00M shares
10-Q · filed 2014-11-06
2014-06-30200.00M shares
10-Q · filed 2014-08-04
2014-03-31200.00M shares
10-Q · filed 2014-05-12
2013-12-31200.00M shares
10-K · filed 2015-02-26
2013-09-30200.00M shares
10-Q · filed 2013-11-07
2013-06-30200.00M shares
10-Q · filed 2013-08-07
2013-03-31200.00M shares
10-Q · filed 2013-05-09
2012-12-31200.00M shares
10-K · filed 2014-03-12
2012-09-30200.00M shares
10-Q · filed 2012-11-09
2012-06-30200.00M shares
10-Q · filed 2012-08-14
2012-03-31200.00M shares
10-Q · filed 2012-05-15
2011-12-31200.00M shares
10-K · filed 2013-03-12
2011-09-30200.00M shares
10-Q · filed 2011-11-14
2011-06-30200.00M shares
10-Q · filed 2011-08-09
2010-12-3118.33M shares
10-K · filed 2012-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Upstream Bio, Inc. (UPB)United States$0.284B-2.42
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Sagimet Biosciences Inc. (SGMT)United States$0.279B
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01